Polmacoxib
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: Polmacoxib (CG 100649) is a first-in-class NSAID drug candidate, is a dual inhibitor... more
Product information "Polmacoxib"
Description: Polmacoxib (CG 100649) is a first-in-class NSAID drug candidate, is a dual inhibitor of carbonic anhydrase (CA) and COX-2. Polmacoxib inhibits premalignant and malignant colorectal lesions in mouse models, partly through inhibiting tumor cell proliferation. Target: Carbonic Anhydrase, COX. Smiles: CC1(C)OC(=C(C1=O)c1cccc(F)c1)c1ccc(cc1)S(N)(=O)=O. References: Kim SH, Margalit O, Katoh H,et al. CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models. Invest New Drugs. 2014 Aug 3. [Epub ahead of print] PubMed PMID: 25085205.
| Keywords: | CG100649, CG 100649, CG-100649 |
| Supplier: | TargetMol |
| Supplier-Nr: | T21294 |
Properties
| MW: | 361.39 D |
| Formula: | C18H16FNO4S |
Database Information
| CAS : | 301692-76-2| Matching products |
| Protein Atlas Nr. : | Biochemicals/Chemicals |
Handling & Safety
| Storage: | -20°C |
| Shipping: | +20°C (International: +4°C) |
| Signal Word: | Warning |
| GHS Hazard Pictograms: |
|
| H Phrases: | H315, H319 |
| P Phrases: | P264, P280, P321, P302+P352, P305+P351+P338, P332+P313, P337+P313, P362+P364 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed